Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
KYMR — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

13.62

Margin Of Safety %

Put/Call OI Ratio

1.79

EPS Next Q Diff

-1.16

EPS Last/This Y

0.13

EPS This/Next Y

-0.81

Price

78.84

Target Price

118.27

Analyst Recom

1.04

Performance Q

-10.79

Upside

-158.8%

Beta

2.04

Ticker: KYMR




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-23KYMR87.151.0410.502608
2026-04-24KYMR84.921.111.432699
2026-04-27KYMR86.761.191.202747
2026-04-28KYMR83.961.210.062848
2026-04-29KYMR81.611.311.082976
2026-04-30KYMR81.051.460.633199
2026-05-01KYMR80.671.460.573198
2026-05-04KYMR83.661.460.233203
2026-05-05KYMR82.751.440.003217
2026-05-06KYMR86.331.412.003249
2026-05-07KYMR84.631.427.883285
2026-05-08KYMR86.11.442.503322
2026-05-11KYMR841.443.333333
2026-05-12KYMR83.621.421.143306
2026-05-13KYMR85.661.430.003315
2026-05-14KYMR84.521.420.403311
2026-05-15KYMR82.261.420.893310
2026-05-18KYMR79.771.901.111549
2026-05-19KYMR78.241.811.141686
2026-05-20KYMR80.631.900.021633
2026-05-21KYMR80.561.781.001668
2026-05-22KYMR78.861.790.101671
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-23KYMR87.18-4.4-35.4-3.60
2026-04-24KYMR84.92-4.4-25.3-3.60
2026-04-27KYMR86.68-4.4-33.1-3.60
2026-04-28KYMR83.81-4.4-20.3-3.60
2026-04-30KYMR80.97-4.4-7.7-3.60
2026-05-01KYMR80.68-4.4-19.8-3.60
2026-05-04KYMR83.57-4.4- -3.60
2026-05-05KYMR82.7523.1- -3.47
2026-05-06KYMR86.3423.1- -3.47
2026-05-07KYMR84.6424.8- -3.44
2026-05-08KYMR86.1424.8- -3.44
2026-05-11KYMR84.1024.8- -3.44
2026-05-12KYMR83.5924.8- -3.54
2026-05-13KYMR85.6324.8- -3.54
2026-05-14KYMR84.4920.3- -3.56
2026-05-15KYMR82.2320.3- -3.56
2026-05-18KYMR79.6620.3- -3.56
2026-05-19KYMR78.1320.3- -3.56
2026-05-20KYMR80.7720.3- -3.56
2026-05-21KYMR80.5620.3- -3.56
2026-05-22KYMR78.8420.3- -3.56
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-23KYMR11.598.0414.79
2026-04-24KYMR11.528.0414.79
2026-04-27KYMR11.527.7413.68
2026-04-28KYMR11.527.7413.68
2026-04-29KYMR11.197.7413.68
2026-04-30KYMR11.527.7413.68
2026-05-01KYMR11.527.7413.68
2026-05-04KYMR11.527.3013.68
2026-05-05KYMR11.527.3013.68
2026-05-06KYMR11.427.3013.68
2026-05-07KYMR11.427.3013.58
2026-05-08KYMR11.427.3013.58
2026-05-11KYMR11.427.5813.58
2026-05-12KYMR11.397.5813.67
2026-05-13KYMR11.397.5813.67
2026-05-14KYMR11.397.5813.67
2026-05-15KYMR11.397.5813.67
2026-05-18KYMR11.397.3413.65
2026-05-19KYMR11.507.3413.65
2026-05-20KYMR11.507.3413.65
2026-05-21KYMR11.507.3413.62
2026-05-22KYMR11.677.3413.62
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

0.13

Avg. EPS Est. Current Quarter

-0.76

Avg. EPS Est. Next Quarter

-1.03

Insider Transactions

11.67

Institutional Transactions

7.34

Beta

2.04

Average Sales Estimate Current Quarter

29

Average Sales Estimate Next Quarter

8

Fair Value

Quality Score

30

Growth Score

25

Sentiment Score

50

Actual DrawDown %

23.5

Max Drawdown 5-Year %

-83.5

Target Price

118.27

P/E

Forward P/E

PEG

P/S

126.05

P/B

4.21

P/Free Cash Flow

EPS

-3.57

Average EPS Est. Cur. Y​

-3.56

EPS Next Y. (Est.)

-4.37

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-611.96

Relative Volume

0.88

Return on Equity vs Sector %

-47.5

Return on Equity vs Industry %

-31.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.04

EBIT Estimation

KYMR Healthcare
$78.89
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
14/20
Pullback
12/25
Volume
7/15
Valuation
10/20
TP/AR
4/10
Options
4/10
RSI
40.8
Range 1M
12.8%
🚀
Momentum Growth
Ride accelerating trends
N/A
33 /100
WEAK
Momentum
7/25
Growth
14/30
Estimates
2/20
Inst/Vol
6/15
Options
4/10
EPS Yr
5.1%
EPS NY
-22.8%
52W%
67.4%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +49.9% upside
Quality
6/30
Valuation
10/30
Growth
9/25
Stability
9/10
LT Trend
1/5
Upside
+49.9%
Quality
30
Kymera Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 253
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing KT-621, an oral STAT6 degrader in Phase 2b clinical trials for moderate to severe atopic dermatitis, asthma, COPD, EoE, CRSwNP, CSU, PN, BP, and others; KT-579, an oral IRF5 degrader in Phase 1 trials for autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, SSc, DM, and others; KT-485/SAR447971, IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis; and cyclin-dependent kinase 2 (CDK2) with broad oncology treatment potential, including in breast cancer and other solid tumors. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
KYMR

Latest News

Caricamento notizie per KYMR
stock quote shares  KYMR – Kymera Therapeutics, Inc. Stock Price stock today
news today  KYMR – Kymera Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch  KYMR – Kymera Therapeutics, Inc. yahoo finance google finance
stock history  KYMR – Kymera Therapeutics, Inc. invest stock market
stock prices KYMR premarket after hours
ticker KYMR fair value insiders trading